These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28273772)

  • 1. Indirect comparisons of treatment effects: Network meta-analyses.
    Sormani MP
    Mult Scler; 2017 Apr; 23(4):510-512. PubMed ID: 28273772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
    Jansen JP; Fleurence R; Devine B; Itzler R; Barrett A; Hawkins N; Lee K; Boersma C; Annemans L; Cappelleri JC
    Value Health; 2011 Jun; 14(4):417-28. PubMed ID: 21669366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
    Hoaglin DC; Hawkins N; Jansen JP; Scott DA; Itzler R; Cappelleri JC; Boersma C; Thompson D; Larholt KM; Diaz M; Barrett A
    Value Health; 2011 Jun; 14(4):429-37. PubMed ID: 21669367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indirect comparison and network meta-analyses--new tools for the assessment of evidence on the relative efficacy of drugs].
    Peura P; Asseburg C; Turunen J; Purmonen T; Martikainen J
    Duodecim; 2011; 127(9):900-10. PubMed ID: 21648163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network analysis of randomized controlled trials in multiple sclerosis.
    Zintzaras E; Doxani C; Mprotsis T; Schmid CH; Hadjigeorgiou GM
    Clin Ther; 2012 Apr; 34(4):857-869.e9. PubMed ID: 22444787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of methodological issues of clinical trials in multiple sclerosis.
    Montalban X
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S35-42. PubMed ID: 22206765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Network meta-analysis: mixed and indirect treatment comparisons. a new method to the service of clinical epidemiology and public health].
    García-Perdomo HA; Tobías A
    Rev Peru Med Exp Salud Publica; 2016 Mar; 33(1):149-53. PubMed ID: 27384635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of adaptive platform trials using a network approach.
    Marschner IC; Schou IM
    Clin Trials; 2022 Oct; 19(5):479-489. PubMed ID: 35993542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect Comparisons and Network Meta-Analyses.
    Kiefer C; Sturtz S; Bender R
    Dtsch Arztebl Int; 2015 Nov; 112(47):803-8. PubMed ID: 26634940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Questionable assumptions hampered interpretation of a network meta-analysis of primary care depression treatments.
    Linde K; Rücker G; Schneider A; Kriston L
    J Clin Epidemiol; 2016 Mar; 71():86-96. PubMed ID: 26524496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planning a future randomized clinical trial based on a network of relevant past trials.
    Salanti G; Nikolakopoulou A; Sutton AJ; Reichenbach S; Trelle S; Naci H; Egger M
    Trials; 2018 Jul; 19(1):365. PubMed ID: 29996869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GetReal in network meta-analysis: a review of the methodology.
    Efthimiou O; Debray TP; van Valkenhoef G; Trelle S; Panayidou K; Moons KG; Reitsma JB; Shang A; Salanti G;
    Res Synth Methods; 2016 Sep; 7(3):236-63. PubMed ID: 26754852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying indirect evidence in network meta-analysis.
    Noma H; Tanaka S; Matsui S; Cipriani A; Furukawa TA
    Stat Med; 2017 Mar; 36(6):917-927. PubMed ID: 27917493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network meta-analysis: an introduction for pharmacists.
    Xu Y; Amiche MA; Tadrous M
    Int J Clin Pharm; 2018 Oct; 40(5):942-947. PubMed ID: 29785685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple formula for enumerating comparisons in trials and network meta-analysis.
    Shokraneh F; Adams CE
    F1000Res; 2019; 8():38. PubMed ID: 30863537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
    Tolley K; Hutchinson M; You X; Wang P; Sperling B; Taneja A; Siddiqui MK; Kinter E
    PLoS One; 2015; 10(6):e0127960. PubMed ID: 26039748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. We can compare the relative efficacy of multiple sclerosis medications by examining the results of independent clinical trials: yes.
    Dahdaleh D; Sharrack B
    Mult Scler; 2015 Jan; 21(1):35-6. PubMed ID: 25392326
    [No Abstract]   [Full Text] [Related]  

  • 18. What can be learned from open direct comparative trials in multiple sclerosis?
    Khan O
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S25-8. PubMed ID: 19200861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-head drug comparisons in multiple sclerosis: Urgent action needed.
    Tur C; Kalincik T; Oh J; Sormani MP; Tintoré M; Butzkueven H; Montalban X
    Neurology; 2019 Oct; 93(18):793-809. PubMed ID: 31591277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported Outcome Measures in Multiple Sclerosis.
    Riazi A
    Int MS J; 2006 Nov; 13(3):92-9. PubMed ID: 17101077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.